Skip to main content
Clinical Trials/CTRI/2024/07/070985
CTRI/2024/07/070985
Not Yet Recruiting
Phase 2

Comparative evaluation of inflammatory biomarkers in gingival crevicular fluid after Mineral Trioxide Aggregate and Biodentine pulpotomy in teeth with Symptomatic Irreversible Pulpitis: An Open label Randomized Controlled Trial. - NI

Dr Ranjana Hanumant Deshmukh0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Ranjana Hanumant Deshmukh
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Ranjana Hanumant Deshmukh

Eligibility Criteria

Inclusion Criteria

  • Patient age 18 \-60 years.Non contributory medical history (ASA1\),Deep caries extending to pulp chamber.Vital mature first mandibular molar with symptoms of irreversible pulpitis.Tooth with positive response to pulp sensibility testing. Clinical diagnosis of irreversible pulpitis with PAI score\=2\.Tooth should be restorable.Tooth with probing pocket depth and mobility should be within normal limits.

Exclusion Criteria

  • Teeth with immature roots.Teeth with clinical sign of pulp necrosis such as swelling or presence of sinus tract .Teeth with prominent radiolucency in the furcation area, presence of internal or external root resorption, any calcification.Teeth with no evidence of bleeding after communication with pulp chamber. Absence of antagonist tooth.
  • Had taken analgesic in past 3 days or antibiotic in past one month.Tooth with periapical lesion visible on radiograph. Teeth in which hemostasis was not achieved in 10 min.

Outcomes

Primary Outcomes

Not specified

Similar Trials